Changes in lifestyle, adiposity, and cardiometabolic markers among young adults in Sweden during the COVID-19 pandemic

Ekström, Sandra; Andersson, Niklas; Kull, Inger; Georgelis, Antonios; Ljungman, Petter; Bergström, Anna

doi:10.1186/s12889-023-15998-w

Cited by 5 publications

(1 citation statement)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lockdown during the COVID-19 pandemic has affected people's lifestyles, such as decreasing physical activity, and increasing consumption of high-calorie and high-energy foods, resulting in fat accumulation in body tissues. This has increased body weight and the prevalence of obesity worldwide (Ekström et al, 2023;Nour and Altintaş, 2023). The prevalence of obesity is expected to continue to increase to 42% in 2025 (Lobstein et al, 2023).…”

Section: Introductionmentioning

confidence: 99%

Development of the Obesity Nutraceutical from Raja and Kepok Banana Peels

Devina,

Indarto,

Susilawati

2023

PICNHS

View full text Add to dashboard Cite

Patients with obesity often fail to control their body weight through diet and physical activity, while the existing anti-obesity drugs have some side effects for long-term use. Banana is Indonesia's tropical fruits with the highest production, and the banana peel has become soil waste. This study aimed to analyze nutrients and active compounds of methanol extracts of raja and kepok banana peels (ERP and EKP respectively). Macro and micro-nutrient compositions of the ERP and EKP were determined using the proximate analysis, while Thin Layer Chromatography (TLC) was used to detect the ERP and EKP active compounds. The ERP contained 0.11% crude fibers, 4.44% fat, and 58.08% carbohydrates, different from the EKP (4.25% protein, 20.95% water, and 14.45% minerals). By contrast, both the ERP and EKP contained flavonoids, phenols, tannins, alkaloids, and saponins. In conclusion, ERP is potentially developed as a nutraceutical for obesity treatment in the future. Further study is needed to measure specific fat levels and to analyze specific active compounds in the ERP which can modulate gene expression and interact with protein targets in lipid metabolism.

show abstract

Section: Introductionmentioning

confidence: 99%

Development of the Obesity Nutraceutical from Raja and Kepok Banana Peels

Devina,

Indarto,

Susilawati

2023

PICNHS

View full text Add to dashboard Cite

show abstract

Glucose tolerance two years after gestational diabetes classified by old Swedish or new WHO diagnostic criteria

Andersson-Hall,

Kristiansson,

Zander

et al. 2024

Diabetes Research and Clinical Practice

View full text Add to dashboard Cite

Snus and Cardiometabolic Health Markers Among Swedish Young Adults

Zettergren,

Andersson,

Pershagen

et al. 2024

Nicotine and Tobacco Research

View full text Add to dashboard Cite

Introduction Snus is suggested as a risk factor for cardiometabolic disease, but little is known about health effects in young populations, particularly in women. We aimed to investigate associations between snus and cardiometabolic health markers among young men and women. Method This study was conducted within the BAMSE birth cohort and included participants followed up around 24 years (n=2256) and 26 years (n=1011). Snus use was assessed at 24 years by questionnaires. Cardiometabolic health markers were recorded at clinical examinations at 24 and 26 years. Associations between snus use and cardiometabolic markers were assessed by multivariable linear regression. Results Snus was used by 6.4% (n=81) among women and 21.9% (n=219) among men. Compared to no tobacco use, daily exclusive snus use among women at 24 years was associated with higher body mass index (BMI) (adjusted β: 1.93 kg/m2, 95% CI: 0.54, 3.33) and waist circumference (WC) (aβ: 3.80 cm, 95% CI: 0.41, 7.18) at 24 years, and with higher BMI (aβ: 2.73 kg/m2, 95% CI: 0.53-4.93) at 26 years. Among men, using ≥4 cans/week was associated with increased BMI (aβ: 2.48 kg/m2, 95% CI: 0.73, 4.24) and a tendency toward increased body fat (aβ: 2.31%, 95% CI: -0.53, 5.14) at 26 years. Snus use was not associated with glycemic status or blood pressure. Conclusion Our results suggest that snus is associated with increased BMI, and possibly other measures of adiposity, among young women and heavy using young men. Given the cross-sectional study design, the results should be interpreted with caution. Implications We found cross-sectional associations between snus use and measures of increased adiposity in a cohort of Swedish young adults, including BMI and waist circumference among women and BMI among heavy snus using men. We did not find associations between snus use and body fat %, glycemic status or blood pressure. This is one of few studies to investigate health effect of snus among both women and men as well as cardiometabolic health markers in young adults. Given the recent trends of increased snus use among young adults, our findings highlight the need for further research on snus on cardiometabolic health.

show abstract

Changes in lifestyle, adiposity, and cardiometabolic markers among young adults in Sweden during the COVID-19 pandemic

Cited by 5 publications

References 38 publications

Development of the Obesity Nutraceutical from Raja and Kepok Banana Peels

Development of the Obesity Nutraceutical from Raja and Kepok Banana Peels

Glucose tolerance two years after gestational diabetes classified by old Swedish or new WHO diagnostic criteria

Snus and Cardiometabolic Health Markers Among Swedish Young Adults

Contact Info

Product

Resources

About